Interestingly, in response to palmitate, selective deletion of ACSL1 in myeloid cells reduces lysosome-dependent NLRP3 inflammasome activation and the production of IL-1β [23], an inflammatory cytokine that is tightly associated with tumor progression, suggesting the role of palmitate in cancer development. The gene discussed is IL1B; the disease is neoplasm.